The safety concerns around shilajit are legitimate. They deserve a direct answer β not reassurance, not dismissal, not marketing spin.
Shilajit contains heavy metals. The supplement is not FDA approved. Memorial Sloan Kettering has flagged safety concerns. Clinical research is limited. Some populations should not take it at all. These are real facts, and pretending otherwise does you no favors.
What those facts mean in practice is more nuanced. This guide walks through each concern using available evidence, explains what has been verified and what remains unknown, and tells you exactly how to determine whether a specific product is safe to use.
What the Research Actually Says About Shilajit Safety
Human clinical data on shilajit safety is limited in volume but not entirely absent. The most relevant published safety study is a 90-day randomized trial published in the Journal of Ethnopharmacology (2009, Shilajit: A review), in which healthy participants received 200β500 mg of processed shilajit daily. Researchers found no significant adverse effects on liver enzymes, kidney function markers, blood pressure, or complete blood count.
A 2016 pilot study in the Andrologia journal assessed shilajit in infertile men over 90 days at 200 mg twice daily and reported no safety signals in biochemical or hematological markers. A 2019 study in the Journal of the International Society of Sports Nutrition found the same dose over 8 weeks in healthy subjects produced no adverse effects on safety biomarkers.
The consistent finding across short-term human trials: processed shilajit at standard doses (200β500 mg/day) does not appear to cause measurable harm in healthy adults over 8β12 week study periods.
The Key Limitations of Existing Research
- β Short duration: Most trials run 8β12 weeks. No multi-year human safety data exists.
- β Small sample sizes: Trials typically include 30β75 participants β too small to detect rare adverse events.
- β Product variability: Studies use specific prepared extracts that may not match commercially available products.
- β Healthy adult focus: Trials exclude pregnant women, people with kidney disease, and other at-risk populations.
The honest summary: available evidence supports reasonable short-term safety for healthy adults using quality-verified products. Long-term safety and safety in vulnerable populations remains insufficiently studied.
The Heavy Metals Problem β Real Risk, Verifiable Solution
Heavy metal contamination is the most substantiated safety concern in shilajit. It is not hypothetical β documented cases of lead and mercury toxicity from shilajit consumption have been reported in the medical literature.
A 2012 case report in the International Journal of Ayurveda Researchdescribed a patient presenting with lead toxicity after consuming an unverified shilajit product. A 2008 study by Saper et al. in the Journal of the American Medical Association found that a significant percentage of Ayurvedic herbal products sold online contained detectable lead, mercury, or arsenic β a category that includes shilajit-containing formulas.
The geological reason is straightforward: shilajit forms in mineral-rich mountain rock over millennia. The same concentration process that yields fulvic acid and trace minerals also concentrates heavy metals from the surrounding geology. Purification reduces but does not eliminate this risk without independent verification.
| Metal | FDA Limit (dietary supplements) | Primary Health Effect at High Exposure | Test Method |
|---|---|---|---|
| Lead (Pb) | <10 ppm | Neurological, cardiovascular | ICP-MS |
| Mercury (Hg) | <3 ppm | Neurological, renal | ICP-MS |
| Arsenic (As) | <15 ppm total | Carcinogenic (inorganic form) | ICP-MS |
| Cadmium (Cd) | <5 ppm | Renal accumulation | ICP-MS |
FDA limits per dietary supplement guidance. ICP-MS (Inductively Coupled Plasma Mass Spectrometry) is the gold standard for trace metal analysis at the ppm and ppb levels required to verify these limits.
The good news: heavy metals contamination is a verifiable risk. Any brand with a current, independently tested Certificate of Analysis (COA) from an accredited laboratory that shows actual measured values β not just a "PASS" stamp β gives you the information you need to assess safety. Our lab data page shows what verified COA documentation looks like for the brands in our database.
Who Should Not Take Shilajit
Several populations have specific reasons to avoid shilajit or to consult a physician before using it. These are not precautionary disclaimers for liability purposes β each category has a documented physiological rationale.
π« Pregnant and Breastfeeding Women
No clinical safety data exists for shilajit use during pregnancy or breastfeeding. Traditional Ayurvedic texts classify shilajit as contraindicated in pregnancy. The presence of heavy metals β even at levels considered safe for healthy adults β takes on additional significance during fetal development, where lead in particular crosses the placental barrier. Until adequate safety data exists, pregnant and breastfeeding women should not use shilajit.
β οΈ Chronic Kidney Disease
Shilajit has been shown to increase urinary uric acid excretion in some studies. In people with impaired kidney function, this effect could be problematic. The kidneys are also the primary elimination route for several heavy metals, and impaired renal function means reduced clearance capacity. People with CKD, kidney stones, or who have had kidney transplants should consult a nephrologist before considering shilajit.
β οΈ Hemochromatosis and Iron Overload Conditions
Shilajit contains trace iron and fulvic acid, which may enhance mineral absorption including iron. For people with hemochromatosis (hereditary iron overload), thalassemia, or other iron storage disorders, increased iron absorption is directly harmful. The same caution applies to anyone receiving iron infusion therapy. People in this category should not take shilajit without explicit medical supervision.
π Potential Medication Interactions
Shilajit's effects on mineral absorption, uric acid metabolism, and reported adaptogenic activity create theoretical interaction risks with certain drug classes. Consult a physician before using shilajit if you take:
- Β· Blood thinners (warfarin, heparin, rivaroxaban)
- Β· Immunosuppressants (cyclosporine, tacrolimus)
- Β· Gout medications (allopurinol, febuxostat)
- Β· Iron supplements or iron-related treatments
- Β· Any medication with narrow therapeutic windows
What Memorial Sloan Kettering Actually Says About Shilajit
Memorial Sloan Kettering Cancer Center maintains an Integrative Medicine database of herbs and supplements, written for clinicians and patients. Their assessment of shilajit is regularly cited in safety discussions, so it is worth addressing directly and accurately.
What MSK's Database Actually States
- βLaboratory evidence exists for anti-inflammatory, antioxidant, and adaptogenic properties in preclinical (cell and animal) studies.
- βHuman clinical evidence is limited. MSK notes that robust randomized controlled trials in humans are sparse, and the existing trials are mostly small and short-term.
- β Heavy metal contamination is flagged as a documented safety concern. MSK notes that quality varies significantly across products and that some commercially available shilajit has been found to contain elevated heavy metals.
- β Lack of standardization is cited. MSK notes that without standardization, the active compound content and safety profile of products sold under the "shilajit" label varies substantially.
- βMSK does not recommend shilajit for cancer treatment, cancer prevention, or as a complementary oncology intervention.
The MSK assessment is measured and accurate, not alarmist. Their safety concerns center on product-level contamination risks and the lack of consistent standards β which are real problems in the supplement market generally, and especially so for shilajit. These concerns are addressed by purchasing from brands that provide independent, accredited lab testing with actual measured values, not marketing claims.
What MSK does not say: that all shilajit is dangerous, that traditional use evidence is irrelevant, or that consumers cannot assess safety. Their concerns are grounded in product variability β a solvable problem for buyers who know how to verify COA data.
How to Read a COA for Safety Markers
A Certificate of Analysis (COA) is the primary tool for verifying shilajit safety. Knowing how to read one correctly is the most practical skill any shilajit buyer can develop.
Our complete COA reading guide covers every section in detail, but for safety specifically, focus on these elements:
β Green Flags
- βSpecific measured values for each heavy metal (e.g., "Lead: 0.06 ppm")
- βTest method stated as ICP-MS
- βISO/IEC 17025 accredited laboratory named
- βAll four metals tested: Pb, Hg, As, Cd
- βReference limits shown alongside results
- βMicrobial panel included (total aerobic count, yeast/mold, E. coli, Salmonella)
- βCOA dated within the last 12β18 months
β Red Flags
- β"Heavy metals tested" claim with no COA link
- βCOA shows only "PASS" without actual numbers
- βIn-house testing by the brand itself
- βMissing one or more of the four key metals
- βNo lab name, accreditation, or LIMS number
- βCOA over 2 years old
- βTest method not stated
You can see real COA documentation for our verified brands on the lab data page. This is what independent, accredited testing looks like β actual values, not marketing language.
What the FDA Says About Shilajit
Shilajit is not FDA approved. Understanding what that actually means β and does not mean β is important for assessing its safety status.
In the United States, shilajit is sold as a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA) of 1994. Under DSHEA:
- Manufacturers are not required to prove efficacy or obtain FDA approval before selling a dietary supplement
- Manufacturers are required to ensure their products are safe and comply with FDA Good Manufacturing Practices (GMPs)
- Disease claims are prohibited β shilajit cannot legally be marketed as treating, curing, or preventing any disease
- The FDA can take action against products after they are on the market if safety problems are identified
This regulatory framework applies to all dietary supplements β protein powders, vitamin D, fish oil, magnesium β not just shilajit. The absence of FDA approval is not a specific shilajit warning; it is the default status for all supplements in the US market.
The FDA has not issued specific safety alerts about shilajit as a category (as of the writing of this guide). Their enforcement actions in the supplement space have focused on products making explicit drug claims, products found to contain undisclosed pharmaceutical compounds, and products with documented heavy metal contamination in post-market testing.
The practical implication: FDA-compliant manufacturing (GMP-certified facilities) and independent third-party testing are your best available tools for safety verification, because pre-market approval is not part of the regulatory model.
Safe Dosage Guidelines
The clinical trials that have studied shilajit safety in humans have used doses in the range of 200β500 mg per day of processed shilajit extract, typically split into two servings. No human trial has demonstrated safety concerns at these doses in healthy adults over the study durations tested (up to 90 days).
| Form | Typical Dose | Notes |
|---|---|---|
| Resin | 250β500 mg/day | Most bioavailable form; dissolve in warm water or under tongue |
| Capsules | 400β500 mg/day | Slower dissolution; convenient; look for resin-filled, not powder |
| Liquid extract | Follow label dosing | Concentration varies β manufacturer's guidance is product-specific |
| Powder | 250β500 mg/day | Higher adulteration risk in this form; verify COA carefully |
Starting at the lower end of the range (around 150β200 mg/day for the first 1β2 weeks) is a prudent approach for first-time users, allowing you to monitor for individual tolerance before increasing to a standard dose.
There is no established safe upper limit based on human data. Doses above 500 mg/day have not been well-studied in clinical settings. Traditional Ayurvedic practice includes cycling protocols (use for several months, followed by a break), though this has not been formally validated in clinical research.
The heavy metals safety math matters here: even at safe total heavy metal concentrations in a COA, higher doses mean higher total daily metal intake. For a product with lead at the FDA limit (10 ppm) in a 500 mg serving, total daily lead intake from shilajit alone would be 5 mcg β well below the FDA Tolerable Daily Intake of 75 mcg for adults. This margin erodes at higher doses, reinforcing the value of using products with metals well below the limit rather than at it.
The only brand in our database with ISO/IEC 17025 accredited lab verification β the highest internationally recognized standard for testing competence. Full heavy metals panel, actual measured values, up to 99.9% purity.
- ISO/IEC 17025 accredited third-party lab testing
- Up to 99.9% pure shilajit β among the highest verified purity
- Sourced from Himalayan & Altai Mountains above 14,000 ft
- No fillers, binders, or additives β 100% pure resin
- Full heavy metals panel included with every batch
- Money-back guarantee + free shipping on orders $45+
Affiliate link β we earn a small commission at no extra cost to you
The Safety Verdict: Conditional Green Light for Healthy Adults
Based on the available evidence, here is the honest safety assessment for shilajit:
Safety Verdict by Population
The safety question for shilajit ultimately reduces to a product question. The compound itself has centuries of traditional use and meaningful short-term clinical data supporting tolerability in healthy adults. The risk is not inherent to shilajit β it is inherent to an unregulated market where product quality varies enormously.
A buyer who verifies a COA from an ISO/IEC 17025-accredited laboratory showing heavy metals well within FDA limits, purchases from a GMP-certified manufacturer, stays within standard dose ranges, and has no contraindicated conditions is operating at an acceptable risk level.
A buyer who purchases based on price or marketing language alone, without verifying any lab data, is taking a genuinely meaningful safety risk.
The brands in our database that have cleared the safety verification bar are documented in our ranked brand guide. Our rating methodology explains exactly how we evaluate COA quality, lab accreditation, and safety documentation. And for the specific heavy metals data on our database brands, see the complete heavy metals guide.
ISO/IEC 17025 accredited lab testing Β· Up to 99.9% pure Β· Himalayan & Altai Mountains source Β· No fillers β a top-tier resin with exceptional purity verification.
- ISO/IEC 17025 accredited third-party lab testing
- Up to 99.9% pure shilajit β among the highest verified purity
- Sourced from Himalayan & Altai Mountains above 14,000 ft
- No fillers, binders, or additives β 100% pure resin
- Full heavy metals panel included with every batch
- Money-back guarantee + free shipping on orders $45+
Affiliate link β we earn a small commission at no extra cost to you
Frequently asked questions
Is shilajit FDA approved?
No. Shilajit is not FDA approved as a drug. It is sold in the United States as a dietary supplement, a category regulated under DSHEA (Dietary Supplement Health and Education Act of 1994). This means manufacturers are not required to prove efficacy before selling, but they are legally prohibited from making disease claims and must comply with FDA Good Manufacturing Practices (GMPs) for supplement production. FDA does not pre-approve dietary supplements before they reach market.
Can shilajit cause heavy metal poisoning?
Untested or low-quality shilajit can contain elevated levels of lead, mercury, arsenic, and cadmium β which at sufficient doses cause heavy metal toxicity. However, reputable brands with published Certificates of Analysis (COAs) from ISO/IEC 17025-accredited independent labs have demonstrated heavy metals within FDA dietary supplement limits. The risk is real but entirely avoidable by purchasing only from brands with verified, publicly accessible lab results.
Who should not take shilajit?
Pregnant and breastfeeding women should avoid shilajit β no safety data exists for these populations. People with chronic kidney disease should exercise caution, as shilajit may increase urinary uric acid levels and some compounds may be renally excreted. Individuals with hemochromatosis or iron overload conditions should avoid shilajit, as it may increase iron absorption. Anyone on blood thinners, immunosuppressants, or medications for kidney or liver conditions should consult a physician before use.
Is shilajit safe long term?
Long-term safety data for shilajit in humans is limited. The available clinical studies are mostly short-term (90 days or less). A 90-day human safety study published in the Journal of Ethnopharmacology found no significant adverse effects at 200β500 mg/day. Centuries of traditional Ayurvedic use provide indirect evidence of tolerability, but this does not substitute for formal long-term clinical data. Healthy adults using verified, low-heavy-metal products at standard doses appear to have a reasonable safety profile, but robust multi-year human trials have not been conducted.
What does Memorial Sloan Kettering say about shilajit?
Memorial Sloan Kettering Cancer Center's Integrative Medicine database lists shilajit as having some laboratory evidence for anti-inflammatory, antioxidant, and adaptogenic effects, but notes that clinical evidence in humans remains limited. MSK specifically flags heavy metal contamination as a safety concern and warns that the supplement is not standardized, meaning product quality varies significantly across brands. MSK does not recommend shilajit for cancer treatment or prevention. Their assessment accurately characterizes shilajit as having preliminary evidence with real quality-control risks that depend entirely on the specific product.
Not sure which shilajit is right for you? Take our free 60-second quiz β